Methylphenidate Hcl Capsule, Extended Release
NDC Package 81842-749-01

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Frequently Asked Questions

Package Information

This product is an UNFINISHED DRUG part of the official NDC directory. Unfinished drugs include products like active ingredients some of which are used in bulk for further processing or compounding. The FDA requires a list of these drugs manufactured in a U.S. commercial distribution facility.

Methylphenidate Hcl capsules is a medication used to treat attention deficit hyperactivity disorder - ADHD. This formulation utilizes a capsule, extended release delivery system. Marketed by Coating Place, Llc, this product is identified by NDC 81842-749.

Identification & Billing

NDC Package Code
81842-749-01
Package Description
13 CAPSULE, EXTENDED RELEASE in 1 DRUM
Product Code
81842-749
11-Digit Billing Format
81842074901

Clinical Specifications

Proprietary Name
Methylphenidate Hcl
Non-Proprietary Name
Methylphenidate Hcl
Substance Name
Methylphenidate
Dosage Form
Capsule, Extended Release - A solid dosage form in which the drug is enclosed within either a hard or soft soluble container made from a suitable form of gelatin, and which releases a drug (or drugs) in such a manner to allow a reduction in dosing frequency as compared to that drug (or drugs) presented as a conventional dosage form.
Active Ingredient(s)
METHYLPHENIDATE 20 mg/1
Usage Information
This medication is used to treat attention deficit hyperactivity disorder - ADHD. It works by changing the amounts of certain natural substances in the brain. Methylphenidate belongs to a class of drugs known as stimulants. It can help increase your ability to pay attention, stay focused on an activity, and control behavior problems. It may also help you to organize your tasks and improve listening skills.
DEA Schedule
Schedule II (CII) Substances

Regulatory & Marketing

Labeler Name
Coating Place, Llc
Product Type
Drug For Further Processing
Marketing Category
DRUG FOR FURTHER PROCESSING - A drug (other than the bulk ingredient API) that is in an interim stage of manufacture, processing, preparation, or packaging, and not ready for human or animal use.
Start Marketing Date
05-20-2019
Listing Expiration
12-31-2027
Exclude Flag
N
Unfinished Product
Yes
Sample Package
N/A

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 81842-749-01 identifies a specific commercial package of 13 capsule, extended release in 1 drum of Methylphenidate Hcl (UNFINISHED drug), drug for further processing labeled by Coating Place, Llc. This capsule, extended release is formulated for use and contains methylphenidate as the active substance.

Is this product currently listed with the FDA?

Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Coating Place, Llc on May 20, 2019. The current certification is valid through December 31, 2027.

What are the primary indications for this medication?

This medication is used to treat attention deficit hyperactivity disorder - ADHD. It works by changing the amounts of certain natural substances in the brain. Methylphenidate belongs to a class of drugs known as stimulants. It can help increase your ability to pay attention, stay focused on an activity, and control behavior problems. It may also help you to organize your tasks and improve listening skills.

How is this Coating Place, Llc product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 81842074901. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-3-2)
81842-749-01
11-Digit CMS (5-4-2)
81842-0749-01

Note: The zero is added to the Product segment to maintain the 5-4-2 structure.